<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000711870"><TermName>FOLFIRINOX regimen</TermName><TermPronunciation>(… REH-jih-men)</TermPronunciation><TermDefinition><DefinitionText>An abbreviation for a chemotherapy combination used to treat pancreatic cancer that has spread to other parts of the body. It includes the drugs leucovorin calcium, fluorouracil, irinotecan hydrochloride, and oxaliplatin. Also called FOLFIRINOX.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000733053" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;FOLFIRINOX regimen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000733054" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;régimen FOLFIRINOX&quot;" language="es" id="_4"/><SpanishTermName>régimen FOLFIRINOX</SpanishTermName><SpanishTermDefinition><DefinitionText>Abreviatura del nombre de una quimioterapia combinada que se usa para tratar el cáncer de páncreas que se diseminó hacia otras partes del cuerpo. Incluye los medicamentos leucovorina cálcica, fluorouracilo, clorhidrato de irinotecán y oxaliplatino.   También se llama FOLFIRINOX.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2011-09-15</DateFirstPublished><RelatedInformation><RelatedDrugSummaryRef href="CDR0000710812">FOLFIRINOX</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
